Home > Healthcare > Pharmaceuticals > Finished Drug Form > anti snoring treatment market
Get a free sample of Anti-snoring Treatment Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Anti-snoring Treatment Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The CPAP devices segment generated USD 426.3 million in 2024 and is expected to grow significantly during the forecast period as they are the standard treatment for obstructive sleep apnea (OSA) and snoring.
The global anti-snoring treatment industry was valued at USD 1.5 billion in 2024 and is projected to grow at a CAGR of 8.5% from 2025 to 2034, driven by the increasing prevalence of sleep disorders.
The U.S. anti-snoring treatment industry recorded USD 559 million in 2024 and is anticipated to witness substantial growth, driven by rising awareness about sleep disorders and their health impacts.
Key players in the market include AccuMED, Airing, Airway Management, Apnea Sciences, Fisher & Paykel Healthcare, GlaxoSmithKline, Illusion Aligners, Koninklijke Philips, Meditas, ResMed, Sleeping Well, and SomnoMed.